Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Long-Term Investments (2016 - 2024)

Historic Long-Term Investments for Sanofi (SNY) over the last 17 years, with Q2 2025 value amounting to $4.0 billion.

  • Sanofi's Long-Term Investments rose 108895.6% to $4.0 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $4.0 billion, marking a year-over-year increase of 108895.6%. This contributed to the annual value of $337.7 million for FY2024, which is 2637.58% down from last year.
  • Latest data reveals that Sanofi reported Long-Term Investments of $4.0 billion as of Q2 2025, which was up 108895.6% from $337.7 million recorded in Q4 2024.
  • In the past 5 years, Sanofi's Long-Term Investments ranged from a high of $4.0 billion in Q2 2025 and a low of $257.7 million during Q2 2021
  • For the 5-year period, Sanofi's Long-Term Investments averaged around $860.5 million, with its median value being $456.2 million (2023).
  • In the last 5 years, Sanofi's Long-Term Investments tumbled by 4209.7% in 2024 and then soared by 108895.6% in 2025.
  • Quarter analysis of 5 years shows Sanofi's Long-Term Investments stood at $286.0 million in 2021, then soared by 141.51% to $690.7 million in 2022, then plummeted by 33.95% to $456.2 million in 2023, then dropped by 25.98% to $337.7 million in 2024, then skyrocketed by 1094.39% to $4.0 billion in 2025.
  • Its Long-Term Investments stands at $4.0 billion for Q2 2025, versus $337.7 million for Q4 2024 and $339.2 million for Q2 2024.